Transmucosal Fentanyl

Transmucosal Fentanyl is a pharmaceutical formulation of fentanyl designed for rapid absorption through mucosal membranes, distinguished from other opioid delivery methods by its targeted use in the management of breakthrough cancer pain via non-invasive, mucoadhesive administration routes such as buccal, sublingual, or nasal mucosa.

113

Publications

7.8K

Citations

463

Authors

246

Institutions

Publications per year

2017–2026

12

Authors

463

  1. TH
    Theodore H. Stanley

    University of Utah, United States

    10 publications · 729 citations

    10

    h-index

  2. JB
    James B. Streisand

    University of Utah, United States

    10 publications · 732 citations

    10

    h-index

  3. NL
    Nathan L. Pace

    University of Utah, United States

    9 publications · 567 citations

    9

    h-index

  4. SM
    Sebastiano Mercadante

    La Maddalena, Italy

    8 publications · 526 citations

    8

    h-index

  5. MA
    M. A. Busch

    University of Wisconsin–Madison, United States

    8 publications · 1.2K citations

    8

    h-index

1–5 of 463

Venues

  1. Anesthesia & Analgesia

    12 publications · 639 citations

    12

    h-index

  2. Anesthesiology

    9 publications · 692 citations

    9

    h-index

  3. Pain

    6 publications · 2K citations

    6

    h-index

  4. PubMed

    Repository · 6 publications · 220 citations

    6

    h-index

  5. Pediatric Anesthesia

    5 publications · 154 citations

    5

    h-index

1–5